Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Eisai (South Korea)
h-index: 7
Total citations: 173
Total papers: 33
Homepage:
http://eisaikorea.com/xe/
Recent papers from Eisai (South Korea)
A phase 2 trial evaluating polysomnography outcomes and safety of lemborexant in Korean adults with insomnia disorder
Scientific Reports · 2026
Safinamide as an adjunct to levodopa monotherapy in Asian patients with Parkinson’s disease experiencing early wearing-off: a pooled analysis of the J-SILVER and KEEP studies
Frontiers in Neurology · 2025
Safety and Effectiveness of Eribulin in Patients with Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes in Real-World Clinical Practice: A 6-Year Post-marketing Surveillance Study in South Korea
Cancer Research and Treatment · 2025
Efficacy and safety of safinamide in Parkinson’s disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study
Journal of Neural Transmission · 2024
Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study
Future Oncology · 2024
A Two-Year Observational Study to Evaluate Conversion Rates from High- and Low-Risk Patients with Amnestic Mild Cognitive Impairment to Probable Alzheimer’s Disease in a Real-World Setting
Journal of Alzheimer s Disease Reports · 2024
Treatment compliance, treatment patterns, and healthcare utilization in epilepsy patients with first add-on antiepileptic drugs: A nationwide cohort study
Heliyon · 2024
Real-world effectiveness of a single conventional disease-modifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study
Journal of Rheumatic Diseases · 2024
Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer’s disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study
BMC Public Health · 2024
Safety and effectiveness of perampanel monotherapy after adjunctive therapy through retention rate in subjects with focal-onset seizures with or without focal to bilateral tonic-clonic seizures: A multicenter retrospective study in Korea
Epilepsy & Behavior · 2023
Factors affecting preventive behaviors of Alzheimer’s disease in family members of patients with Alzheimer’s disease
Medicine · 2022
Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures in the FAME Study: Post hoc Analyses of Dose-Related Efficacy, Safety and Clinical Factors Associated with Response
Journal of Epilepsy Research · 2022
Perampanel as First Add-On Therapy in Patients with Focal-Onset Seizures in the FAME Trial: Post hoc Analyses of Efficacy and Safety Related to Maintenance Dose and Background Antiepileptic Drug Therapy
Journal of Epilepsy Research · 2022
Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases
Scientific Reports · 2022
Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
Epilepsy & Behavior · 2021
Long-term efficacy and safety of perampanel as a first add-on therapy in patients with focal epilepsy: Three-year extension study
Epilepsy & Behavior · 2021
First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
Acta Neurologica Scandinavica · 2019
Effect of Ursolic Acid on the Development of Mouse Embryonic Stem Cells under Hypoxia
Journal of Life Science · 2013
Mortality and Incidence of Malignancy in Korean Patients with Rheumatoid Arthritis
The Journal of Rheumatology · 2011